This week we have the one and only Peter Mantas of Logos LP. This episode is the second time we solely focused on life sciences and the Biotech space. Peter explains how much the biotech and life sciences industry has change since the last time we spoke all the way back in February. He explains why Big Pharma might have a golden age, how to value the pipeline for some pharmaceuticals companies, gaging probabilities, what is bioprocessing, who are the C players and more!

• [0:00] What has changed since February?
• [10:30] The Golden Age of Big Pharma
• [18:00] The possible next big Pharma player
• [25:00] How to value the pipeline?
• [30:00] Gaging Probabilities
• [33:00] Strong Barriers to Entry
• [43:00] Who are the C players?
• [49:00] Management Teams
• [52:00] What is Bioprocessing?
• [1:09:00] LLY’s Relative Strength
• [1:16:00]Twitter Questions

If you enjoyed this episode, go follow Peter on Twitter @Logos_LP.

Finally, a big thanks to the following sponsors for making the podcast a reality.

Mitimco

This episode is brought to you by MIT Investment Management Company, also known as MITIMCo, the investment office of MIT. Each year, MITIMCo invests in a handful of new emerging managers who it believes can earn exceptional long-term returns in support of MIT's mission. To help the emerging manager community more broadly, they created emergingmanagers.org, a website for emerging manager stockpickers.

For those looking to start a stock-picking fund or just looking to learn about how others have done it, I highly recommend the site. You'll find essays and interviews by successful emerging managers, service providers used by MIT's own managers, essays MITIMCo has written for emerging managers and more!

Tegus

Tegus has the world’s largest collection of instantly available interviews on all the public and private companies you care about. Tegus actually makes primary research fun and effortless, too. Instead of weeks and months, you can learn a new industry or company in hours, and all from those that know it best.

I spend nearly all my time reading Tegus calls on existing holdings and new ideas. And I know you will too. So if you’re interested, head on over to tegus.co/valuehive for a free trial to see for yourself.

TIKR

TIKR is THE BEST resource for all stock market data, I use TIKR every day in my process, and I know you will too. Make sure to check them out at TIKR.com/hive.

--- Support this podcast: https://podcasters.spotify.com/pod/show/valuehive/support